Twist Bioscience ( (TWST) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Twist Bioscience’s stock has experienced a downturn primarily due to its Q3 earnings report, which, despite showing record revenue and improved gross margins, has led analysts to lower price targets. This adjustment reflects concerns over cautious near-term growth in the SynBio segment, even though the NGS performance remains strong. Additionally, negative insider sentiment, marked by increased share sales and narrowed FY25 revenue guidance, has further shaken investor confidence.
More about Twist Bioscience
YTD Price Performance: -25.67%
Average Trading Volume: 1,102,982
Technical Sentiment Signal: Sell
Current Market Cap: $2.02B
For further insights into TWST stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.
This story was written using TipRanks's AI tools and reviewed by a TipRanks editor.